Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis

AIDS Research and Human Retroviruses

Volumn 28, Issue 10, 2012, Pages 1216-1219

  Price, Patricia ^a   Haddow, Lewis J ^b   Affandi, Jacquita ^a   Agarwal, Upasna ^c   Easterbrook, Philippa J ^d   Elliott, Julian ^e   French, Martyn ^a   Kumar, Manoj ^f   Moosa, Mahomed Yunus S ^c   Oliver, Benjamin ^a   Singh, Sarman ^f   Sola, Marcelo ^a   Saphonn, Vonthanak ^g   Vun, Mean Chhi ^g  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LRS Institute of TB and Respiratory Diseases   (India)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e BURNET INSTITUTE   (Australia)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^g National Institute of Public Health   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; BLOOD SAMPLING; CAMBODIA; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; DNA DETERMINATION; ENDEMIC DISEASE; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; MAJOR CLINICAL STUDY; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEPTOR GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; T LYMPHOCYTE; TUBERCULOSIS; VDR FOKI GENE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALLELES; ANTI-HIV AGENTS; CAMBODIA; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; SOUTH AFRICA; TUBERCULOSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866685328     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0272     Document Type: Review

References (17)

1. Price P, Agarwal U, Murdoch D, Elliot J, Lewin S, and French M: Immune restoration diseases reflect diverse im-munopathological mechanisms. Clin Microbiol Rev 2009;22: 651-663.
2. Gauzzi MC, Purificato C, Donato K, Jin Y, Wang L, Daniel KC, et al.: Suppressive effect of 1 a,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemo-taxis. J Immunol 2005;174:270-276.
3. Morales-Tirado V, Wichlan DG, Leimig TE, Street SE, Kasow KA, and Riberdy JM: 1a,25-Dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin Immunol 2011;138:212-221.
4. Liu PT, Stenger S, Tang DH, and Modlin RL: Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179:2060-2063.
5. Sasidharan PK, Rajeev E, and Vijayakumari V: Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002;50: 554-558.
6. Tostmann A, Wielders JP, Kibiki GS, Verhoef H, Boeree MJ, and van der Ven AJ: Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. Int J Tuberc Lung Dis 2010;14:1147-1152.
7. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, and Tangpricha V: Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr Pract 2009;15:438-449.
8. Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, and Sterling TR: Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet 2010;11:37.
9. Gao L, Tao Y, Zhang L, and Jin Q: Vitamin D receptor genetic polymorphisms and tuberculosis: Updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010;14:15-23.
10. Haug CJ, Aukrust P, Haug E Mørkrid L, Müller F, and Frøland SS: Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998;83: 3832-3838.
11. Welz T, Childs K, Ibrahim F, Poulton M, Taylor CB, Moniz CF, and Post FA: Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase AIDS 2010; 24:1923-1928.
12. Conesa-Botella A, Mathieu C, Colebunders R, Moreno-Reyes R, van Etten E, Lynen L, and Kestens L: Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome? AIDS Res Ther 2009;6:4.
13. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, et al.: Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009;200:1736-1745.
14. Haddow LJ, Moosa MYS, and Easterbrook PJ: Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010;24: 103-108.
15. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al.: Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20:1807-1814.
16. Ho-Pham LT, Nguyen ND, Nguyen TT, Nguyen DH, Bui PK, Nguyen VN, and Nguyen TV: Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis 2010;10:306.
17. Alagarasu K, Selvaraj P, Swaminathan S, Narendran G, Narayanan PR, et al.: 5' regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol 2009 29:196-204.